CalcMyPeptide
5-Amino-1MQ: The NNMT Inhibitor That Raises NAD+ and Targets Fat
Longevity

5-Amino-1MQ: The NNMT Inhibitor That Raises NAD+ and Targets Fat

11 min read

5-Amino-1MQ inhibits NNMT to raise intracellular NAD+ and reduce fat storage. Mechanism, dosing, evidence, and comparison.

Table of Contents

⚕️ Medical Disclaimer: This article is for educational and informational purposes only. It does not constitute medical advice. Consult a qualified healthcare provider before using any peptide.

⚕️ Medical Disclaimer

**⚕️ Medical Disclaimer:** This article is for educational and informational purposes only. It does not constitute medical advice. Consult a qualified healthcare provider before using any compound.

What Is 5-Amino-1MQ and How Does It Target Fat?

5-Amino-1MQ is a small molecule inhibitor of nicotinamide N-methyltransferase (NNMT) — an enzyme that degrades NAD+ and promotes fat cell enlargement. By blocking NNMT, 5-Amino-1MQ raises intracellular NAD+ levels and shifts fat cell metabolism from storage toward oxidation. In preclinical models, NNMT inhibition reduced body weight, decreased total cholesterol, and shrank white adipose tissue volume without affecting food intake (Neelakantan et al., 2018, [PMID: 30131221](https://pubmed.ncbi.nlm.nih.gov/30131221/)).

*Last updated: March 2026*

This is not a peptide — it is a small molecule (MW 173 Da). We include it because 5-Amino-1MQ is frequently stacked with peptides in the longevity and fat loss communities.

5-Amino-1MQ Dosing Protocol

**Standard dose:** 50-150 mg orally, 1-2× daily. Most protocols use 100 mg twice daily (200 mg/day total). **Form:** oral capsule. **Cycle:** 8-12 weeks, then 4-week break. No reconstitution required — oral dosing only.

Can be combined with injectable fat loss peptides (AOD-9604, semaglutide). For injectable reconstitution math, use the [Reconstitution Calculator](/en/reconstitution-calculator).

How NNMT Inhibition Raises NAD+ and Burns Fat

NNMT (nicotinamide N-methyltransferase) catalyzes the methylation of nicotinamide (NAM) to 1-methylnicotinamide (1-MNA), effectively removing NAD+ precursors from the salvage pathway. When NNMT is overactive (as in obesity and aging), NAD+ levels drop, fat storage increases, and energy metabolism slows. 5-Amino-1MQ blocks this enzyme, allowing more NAM to be recycled back into NAD+ via NAMPT → NMN → NAD+.

Higher NAD+ activates sirtuins (SIRT1-7) — the "longevity enzymes" that regulate mitochondrial biogenesis, DNA repair, and fatty acid oxidation. This mechanism links 5-Amino-1MQ to both fat loss and anti-aging — see our [Epitalon and longevity peptides](/en/blog/epitalon-longevity-peptides) guide for the longevity angle.

5-Amino-1MQ vs NMN vs NR: NAD+ Boosting Comparison

Feature5-Amino-1MQNMNNR (Niagen)
MechanismBlocks NAD+ degradation (NNMT)Provides NAD+ precursorProvides NAD+ precursor
Fat Loss Effect✅ Direct (adipocyte metabolism)Minimal directMinimal direct
NAD+ BoostModerate (preserves existing)Moderate (provides substrate)Moderate (provides substrate)
RouteOral capsuleOral capsule/sublingualOral capsule
Human DataLimited (preclinical)Emerging Phase 2Some clinical data
Cost$80-150/month$40-80/month$30-60/month

Frequently Asked Questions

**Is 5-Amino-1MQ a peptide?** No, it is a small molecule (MW 173 Da). We cover it because of its popularity in the peptide community for fat loss stacking.

**Can I stack 5-Amino-1MQ with semaglutide?** Yes — different mechanisms (NNMT inhibition vs GLP-1R agonism). No known interaction. See [stacking 101](/en/blog/peptide-stacking-101).

**What are the side effects?** Limited human data. Preclinical data shows no observed toxicity at therapeutic doses. Anecdotal reports include mild GI discomfort at higher doses.

**Is 5-Amino-1MQ legal?** Not FDA-approved, not a controlled substance. Available through compounding pharmacies or as a research compound.

**How long until results?** Most users report noticeable changes in body composition at 4-8 weeks of consistent daily use when combined with exercise and caloric awareness.

Related Articles